Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, has announced a collaboration with ...

Type 2: Increased CSA in monofascicular nerves. This pattern may be seen in the brachial plexus and cervical nerve roots in inflammatory neuropathies, such as GBS and CIDP, and hereditary neuropathies ...

GBS, a neurological condition triggered by an overactive immune system often after viral or bacterial infections, has been ...

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a progressive or relapsing neuropathy likely caused by an autoimmune attack on the peripheral nerves. A number of treatment ...

We are positioned for significant expansion in 2025 with the FDA decision on approval of our pre-filled syringe, global CIDP rollout, and label-expansion studies underway for MG. To further ...

We are positioned for significant expansion in 2025 with the FDA decision on approval of our pre-filled syringe, global CIDP rollout, and label-expansion studies underway for MG. To further support ...

Campylobacter jejuni (C. jejuni), a bacterium known to cause foodborne illness, is one of the most common infectious agents linked with GBS and also the reason behind the recent outbreak of GBS in ...

The recent outbreak of Guillain–Barré syndrome (GBS), a rare neurological condition in Pune, Maharashtra, has led to panic among the public in Maharashtra and other parts of India.

A 41-year-old chartered accountant (CA) has been confirmed as the first casualty of the Guillain-Barre Syndrome (GBS) outbreak in Pune, which has seen a surge in cases since early January.

The number of suspected deaths in Maharashtra due to Guillain-Barré Syndrome (GBS), a rare nerve disorder, have risen to four, while the tally of cases recorded in the state so far stood at 140 ...

Western India's city of Pune is battling rising cases of an immune disorder, the Guillian-Barré Syndrome (GBS). At least one person has died of the rare condition. India's western city of Pune is ...